Skip to main content
. 2015 Mar 7;35(9):1473–1478. doi: 10.1007/s00296-015-3236-y

Table 3.

Medication use for ankylosing spondylitis patients during the 3-month pre-index period

All patients, (n = 648)
n (%)
Biologic agents 431 (66.5)
DMARDs 327 (50.5)
NSAI agents 244 (37.7)
NSAI topical agents 131 (20.2)
Paracetamol 17 (2.6)
Glucocorticoids 67 (10.3)
Gastroprotective agents 187 (28.9)

DMARD disease-modifying antirheumatic drug, NSAI non-steroidal anti-inflammatory